← Open Payments lookup

MEGAN CASTILLO: Open Payments

NPI 1447781091 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,897 in 165 payments from 22 companies in 2025. Trend: 2023 $27 · 2024 $3,714 · 2025 $3,897

Food & beverage: $3,897
CompanyPaymentsAmount
ABBVIE INC.57$1,095
Ipsen Biopharmaceuticals, Inc7$392
Janssen Biotech, Inc.11$360
Takeda Pharmaceuticals U.S.A., Inc.11$331
Regeneron Healthcare Solutions, Inc.7$253
Madrigal Pharmaceuticals11$225
Ardelyx, Inc.6$196
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$170
Aimmune Therapeutics, Inc.11$168
Phathom Pharmaceuticals, Inc.6$133

Products named: RINVOQ, IQIRVO, DUPIXENT, TREMFYA, LINZESS, ENTYVIO, REZDIFFRA, SKYRIZI.

Industry payments across TX — which companies pay providers there.